As GLP-1 medications like Ozempic soar in popularity, our new documentary follows three people on their weight-loss journeys ...
Jamie Chung for The New York Times Supported by By Tomas Weber Trinian ... Auerbach was trying to understand the shopping behavior of Ozempic users, and Taylor was one of her case studies.
President-elect Donald J. Trump is set to nominate Robert F. Kennedy Jr. to lead the Health and Human Services Department, ...
New research shows that weight loss medications can stop the progression of prediabetes. Experts don’t all agree on such a ...
He took a faculty position at what was then the State University of New York Health Science Center ... the consequences transformed society: Ozempic and Wegovy, followed by Mounjaro and Zepbound ...
If the proposal is finalized, it could set the stage for a showdown between the pharmaceutical industry and the Trump ...
The pharmaceutical manufacturer Amgen announced on Tuesday that an experimental obesity drug helped patients lose up to 20 ...
Ozempic — or any of the GLP-1 class of diet drugs that includes Wegovy and Mounjaro — hasn’t just changed our nation’s ...
The makers of weight loss drugs and Robert F. Kennedy Jr. are both pushing for Americans to change their diets. But the owner ...